Its phase 1/2 trial – lasting 18 months and due to ... a preventable disease through vaccination." Another candidate chlamydia vaccine – CTH522 from Denmark's Statens Serum Institut (SSI ...

Researchers at Umeå University, Sweden, and Michigan State University, U.S., have discovered a type of molecule that can kill chlamydia bacteria, but spare bacteria that are important for health.

45. A closely watched clinical trial testing what could be the world’s first new tuberculosis vaccine in a century has hit its enrollment target, ahead of expectations. The Phase 3 study of ...

A study at a sexual health clinic finds that significant declines in chlamydia and syphilis were sustained nearly 2 years ...

The study was a phase 3 clinical trial on GSK’s Arexvy vaccine, which was published April 14 in The Lancet Respiratory Medicine. The findings were the first that tracked vaccine efficacy over ...

WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to ...